01/16/2025
9:40 AM | Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
| Form SCHEDULE 13G | |
01/13/2025
7:00 AM | Kazia Therapeutics (Filer)
| Form 424B5 | |
01/13/2025
7:03 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025
7:05 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/13/2025
7:07 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
01/10/2025
7:00 AM | Kazia Therapeutics (Filer)
| Form 424B5 | |
12/31/2024
7:46 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/31/2024
7:49 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/31/2024
7:43 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/11/2024
8:01 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/11/2024
8:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
|
12/11/2024
7:58 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/03/2024
3:33 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/03/2024
3:38 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
12/02/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
12/02/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
11/27/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
11/27/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form POS AM | |
11/06/2024
6:53 PM | Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
| Form SC 13G | |
11/01/2024
3:05 PM | Kazia Therapeutics (Filer)
| Form NT 20-F | |
10/24/2024
7:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024
7:33 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024
7:38 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/24/2024
7:22 AM | Kazia Therapeutics (Filer)
| Form 6-K/A | |
10/15/2024
6:01 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024
6:03 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024
6:04 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/15/2024
6:06 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
3:52 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
3:55 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
10/02/2024
3:57 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024
8:27 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024
8:23 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024
8:25 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/23/2024
8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024
8:06 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024
8:10 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024
8:12 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/13/2024
8:14 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
09/12/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
09/04/2024
7:56 PM | Kazia Therapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
$2 Trillion Disappears Because of Fed's Secretive New Move (Ad) $2 trillion has disappeared from the US government's books.
The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth. Click here to see his new research now. |
08/12/2024
6:28 PM | Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
| Form SC 13G/A | |
07/10/2024
8:26 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024
8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024
8:28 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
07/10/2024
8:19 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/02/2024
4:29 PM | Alumni Capital LP (Filed by)
Kazia Therapeutics (Subject)
| Form SC 13G | |
06/28/2024
3:27 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
06/24/2024
7:14 PM | Kazia Therapeutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
06/04/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
05/29/2024
7:55 AM | Kazia Therapeutics (Filer)
| Form F-1
Registration statement for securities of certain foreign private issuers | |
05/23/2024
6:00 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2024
6:03 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
05/01/2024
3:01 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/01/2024
3:06 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
04/19/2024
3:26 PM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/19/2024
3:30 PM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024
7:37 AM | Kazia Therapeutics (Filer)
| Form 424B3 | |
03/27/2024
7:26 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/26/2024
7:02 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/21/2024
8:19 AM | Kazia Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024
2:41 PM | ARMISTICE CAPITAL, LLC (Filed by)
Kazia Therapeutics (Subject)
| Form SC 13G | |
02/12/2024
5:35 PM | Kazia Therapeutics (Subject)
PLATINUM INVESTMENT MANAGEMENT LTD (Filed by)
| Form SC 13G | |
02/05/2024
11:15 PM | Kazia Therapeutics (Filer)
| Form EFFECT | |
